Two new cannabinoid programs

Update | Pharmaceutical & healthcare | 17/11/2017

Rebasing the business

Update | Technology | 17/11/2017

Well funded for growth

Outlook | Technology | 17/11/2017

Irons in the fire

Update | Technology | 17/11/2017

Glory, glory, Man United

Review | Investment Companies | 16/11/2017

Seeking to prevent or treat breast cancer

Outlook | Pharmaceutical & healthcare | 16/11/2017

Weaker order intake in Q4

Update | General Industrials | 16/11/2017

Investing to build

Update | Media | 16/11/2017

A new BTK for a new day

Outlook | Pharmaceutical & healthcare | 16/11/2017

A world of new surfaces

QuickView | General Industrials | 16/11/2017

Growing revenues and investing for the future

Update | Financials | 16/11/2017

Positive Q317 performance; Q417 tender offer

Update | Investment Companies | 16/11/2017

ATACking cancer cells with novel technology

QuickView | Pharmaceutical & healthcare | 16/11/2017

Emerging market fintech

QuickView | Financials | 15/11/2017

Restructured for growth

QuickView | Technology | 15/11/2017

Leading online brokerage

QuickView | Technology | 15/11/2017

Acting towards transition

QuickView | Engineering | 15/11/2017

Recovery continues

Update | Food & Drink | 15/11/2017

Q3 update gives reassurance and upgrade

Update | Media | 15/11/2017

Powering up

Initiation | Industrial Support Services | 15/11/2017

Strategic refocus in progress

QuickView | Financials | 15/11/2017

H117 results released, business on track

Update | Pharmaceutical & healthcare | 15/11/2017

A new chapter with a bright future

Update | Aerospace & Defence | 15/11/2017

Strong H1 performance

Update | Industrial Support Services | 15/11/2017

Sales recovery sees strategy on track

Update | Consumer Support Services | 15/11/2017

Green light for Spherox from the EMA

QuickView | Pharmaceutical & healthcare | 15/11/2017

Proprietary software driving growth

QuickView | Technology | 14/11/2017

Profiting from digital transformation

QuickView | Technology | 14/11/2017

A sporting chance

QuickView | Media | 14/11/2017

Biosimilar enoxaparin launches

Update | Pharmaceutical & healthcare | 14/11/2017

Funds raised to support VCSEL ramp-up

Update | Technology | 14/11/2017

An attractive deleveraging bet

Outlook | Travel & Leisure | 14/11/2017

Aneth adds another antler

Update | Oil & Gas | 13/11/2017

The stars are aligning for fast growth in the US

Outlook | Pharmaceutical & healthcare | 13/11/2017

Profits dip as expected with FY18 recovery underway

Update | Consumer staples | 13/11/2017

Long-term Thai equities specialist

Review | Investment Companies | 13/11/2017

Increasing exposure to continental Europe

Review | Investment Companies | 13/11/2017

Piercing the gloom

Update | Automotive Retailers | 13/11/2017

Loan growth and ROE are positive features

Update | Financials | 13/11/2017

Associate Rail Vision looking at Nasdaq listing

Flash note | Technology | 13/11/2017

Strong volumes in tougher trading environment

Update | Industrial Support Services | 12/11/2017

Termination of coverage

Update | Mining | 12/11/2017

Termination of coverage

Update | Alternative Energy | 12/11/2017

Termination of coverage

Update | Financials | 12/11/2017

Termination of coverage

Update | General Industrials | 12/11/2017

Termination of coverage

Update | Automotive Retailers | 12/11/2017

Termination of coverage

Update | Consumer Support Services | 12/11/2017

Termination of coverage

Update | Pharmaceutical & healthcare | 12/11/2017

Never knowingly undersold

Update | Mining | 10/11/2017

No distractions from the search for growth

QuickView | Pharmaceutical & healthcare | 10/11/2017

Licensing and funding milestones in Q3

Update | Pharmaceutical & healthcare | 10/11/2017

Supercharged

QuickView | Consumer Support Services | 10/11/2017

US and Japan filings and EU Phase III on track

Update | Pharmaceutical & healthcare | 10/11/2017

Income growth and growing NAV

Update | Property | 09/11/2017

TCR clinical trial initiation imminent

Update | Pharmaceutical & healthcare | 09/11/2017

Priming immune response in anticancer combos

Initiation | Pharmaceutical & healthcare | 08/11/2017

New manager oversees improved performance

Review | Investment Companies | 08/11/2017

Novel treatments for worldwide unmet needs

Initiation | Pharmaceutical & healthcare | 07/11/2017

Growing into an improving market

Update | Property | 07/11/2017

Cloud OEM agreement with Virtustream/Dell

Update | Technology | 07/11/2017

Waiting for readouts

Update | Pharmaceutical & healthcare | 07/11/2017

Making the most of it

Flash note | Travel & Leisure | 06/11/2017

Fully funded to complete pre-development goals

Update | Mining | 03/11/2017

Benefits from announced debt refinancing

Review | Investment Companies | 03/11/2017

Restructured for growth

Initiation | Technology | 03/11/2017

Aplidin and Zepsyre milestones coming up

Update | Pharmaceutical & healthcare | 03/11/2017

Positioning the business for growth

Update | Technology | 03/11/2017

Revenue growth and continued executions

Update | Technology | 02/11/2017

New initiatives from US small-cap value specialist

Review | Investment Companies | 02/11/2017

Transition management continues

QuickView | Aerospace & Defence | 02/11/2017

Hurricane hoping for a storm-less 2018

Update | Oil & Gas | 02/11/2017

Tulu Kapi financial projections update

Update | Mining | 02/11/2017

New formulations extend Treakisym patent life

ADR Update | Pharmaceutical & healthcare | 02/11/2017

Self-service growth kicking in

Update | Media | 01/11/2017

INEOS acquires interest in Egdon core shale area

Update | Oil & Gas | 01/11/2017

Gaining the industry attention it deserves

Update | Mining | 01/11/2017

Multiple assets in the clinic as data readouts near

Update | Pharmaceutical & healthcare | 01/11/2017

Sale of Digital Payments division

QuickView | Media | 01/11/2017

Heavy investment is beginning to pay off

Outlook | Technology | 01/11/2017

Debt maturity extensions

Flash note | Oil & Gas | 31/10/2017

H117 results and update

Update | General Industrials | 31/10/2017

Well placed for China’s coming ADAS revolution

Outlook | Technology | 31/10/2017

Revision of clinical strategy after responses seen

ADR Update | Pharmaceutical & healthcare | 30/10/2017

Careful investment paying dividends

Update | Property | 30/10/2017

Becoming a dermato-oncology expert

Outlook | Pharmaceutical & healthcare | 30/10/2017

Revision of clinical strategy after responses seen

Update | Pharmaceutical & healthcare | 30/10/2017

Near-term expectations reduced

Update | Industrial Support Services | 30/10/2017

Material progress for HomeSend

Update | Technology | 30/10/2017

Fibreless optical links in the skies

Initiation | Technology | 30/10/2017

Reinvestment in asset growth

Outlook | Alternative Energy | 30/10/2017

Unique fund structure offering income and growth

Review | Investment Companies | 27/10/2017

Unique fund structure offering income and growth

Review | Investment Companies | 27/10/2017

Slower pipeline conversion

Update | Technology | 27/10/2017

Making good progress

Update | Financials | 27/10/2017

Diverse customer base highlights the opportunity

Update | Technology | 27/10/2017

Asset management delivers strong capital growth

Update | Investment Companies | 27/10/2017

Outperformance down to stock selection

Review | Investment Companies | 26/10/2017

Pursuing Phase 1 capital

Update | Mining | 25/10/2017

Market trends help but costs and forex hinder

Update | Financials | 25/10/2017

Higher, more realistic benchmark introduced

Review | Investment Companies | 25/10/2017